A detailed history of Sepio Capital, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Sepio Capital, LP holds 20,042 shares of NVO stock, worth $2.07 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
20,042
Previous 20,196 0.76%
Holding current value
$2.07 Million
Previous $2.88 Million 17.21%
% of portfolio
0.23%
Previous 0.31%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $18,336 - $22,394
-154 Reduced 0.76%
20,042 $2.39 Million
Q2 2024

Aug 15, 2024

SELL
$122.71 - $146.91 $9,571 - $11,458
-78 Reduced 0.38%
20,196 $2.88 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $201,156 - $267,762
-1,970 Reduced 8.86%
20,274 $2.6 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $303,806 - $364,962
-3,461 Reduced 13.46%
22,244 $2.3 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $1.18 Million - $2.6 Million
13,012 Added 102.51%
25,705 $2.34 Million
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $79,237 - $87,706
-508 Reduced 3.85%
12,693 $2.05 Million
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $268,253 - $322,576
-2,027 Reduced 13.31%
13,201 $2.1 Million
Q4 2022

Feb 03, 2023

SELL
$102.55 - $135.33 $237,300 - $313,153
-2,314 Reduced 13.19%
15,228 $2.06 Million
Q3 2022

Oct 28, 2022

SELL
$95.28 - $116.93 $66,886 - $82,084
-702 Reduced 3.85%
17,542 $1.75 Million
Q2 2022

Jul 26, 2022

SELL
$103.24 - $121.81 $62,150 - $73,329
-602 Reduced 3.19%
18,244 $2.03 Million
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $124,102 - $150,015
-1,333 Reduced 6.61%
18,846 $2.09 Million
Q4 2021

Jan 25, 2022

BUY
$95.88 - $117.08 $4,410 - $5,385
46 Added 0.23%
20,179 $2.26 Million
Q3 2021

Nov 03, 2021

BUY
$84.42 - $106.62 $7,935 - $10,022
94 Added 0.47%
20,133 $1.93 Million
Q2 2021

Jul 26, 2021

SELL
$67.66 - $84.76 $155,279 - $194,524
-2,295 Reduced 10.28%
20,039 $1.68 Million
Q1 2021

May 10, 2021

BUY
$67.06 - $75.82 $1.5 Million - $1.69 Million
22,334 New
22,334 $1.51 Million
Q3 2019

Oct 25, 2019

SELL
$47.54 - $53.43 $3.4 Million - $3.83 Million
-71,604 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$46.79 - $52.47 $16,470 - $18,469
-352 Reduced 0.49%
71,604 $3.66 Million
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $457,109 - $518,931
-9,860 Reduced 12.05%
71,956 $3.76 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $3.4 Million - $3.87 Million
81,816 New
81,816 $3.77 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sepio Capital, LP Portfolio

Follow Sepio Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.